Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA-Matched Cadaveric Donors

NCT01852370 is registered in ClinicalTrials.gov with Paul Szabolcs as lead sponsor.

NCT NCT01852370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01852370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA-Matched Cadaveric Donors
Lead sponsor
Paul Szabolcs
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
June 20, 2013
Completion date
November 30, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic granulomatous disease (cgd), common variable immune deficiency (cvid), hyper ige syndromes, hyper igm deficiencies, immunodeficiency with predominant t-cell defect, unspecified, mendelian susceptibility to mycobacterial disease, severe chronic neutropenia, severe combined immunodeficiency (scid), wiskott-aldrich syndrome